Join us on 14 July for your next Pharma Connect event in partnership with Durham University’s Orbit and CPI.

Pharma Connect focuses on developing the pharmaceutical and supply chain community through engagement, introductions, best practice sharing and networking.
 

Join us to hear how the Orbit facility is encouraging collaboration and innovation within the SME community, leading the next generation of technology for the science and pharmaceutical sectors.

CPI will also discuss their extensive pharma offering and showcase how manufacturers and SMEs can engage. Information will also be shared about the exciting new Medicines Manufacturing Innovation Centre in Glasgow which is pioneering two grand challenges centred around continuous direct compression and just-in-time supply.

There will also be the opportunity to have a guided tour* of CPI’s National Formulations Centre. 30 minute tours are available for members, on a first come first served basis, at 12:30, 15:00 and 15:45. Please book the ticket with the tour time that you’d like.

* If you have booked on to a tour, we will be in touch detailing CPI’s Covid-19 policy

Our Speakers

• Chris Mullen – Pharmaron –  History of the Cramlington site, history of Pharmaron and the challenges/opportunities in the change to our business model under the rebrand from Recipharm to Pharmaron

• Dr David Weinkove – Magnitude Biosciences – Will introduce their technology and discuss the benefits of being based at the Orbit Offices
• Dr Paul Chazot – Durham University – Rational drug design for refractory neurological diseases: the Jim Black approach
• CPI – Discussion of their pharmaceutical offering and introduction to the Medicines Manufacturing Innovation Centre

Exclusive to NEPIC members.
Places are free but limited. 

We look forward to seeing you there!

Get social: Tweet that you’re attending #pharmaconnect and we’ll re-tweet to our followers! @NEPIC_Ltd

Competition Law Statement

Trade association meetings have, in the past, been used as a forum for the establishment of cartels and they are therefore the subject of scrutiny by the UK Competition and Markets Authority.

For the purposes of remaining compliant with competition law, members should not discuss commercially sensitive strategic information (including but not limited to, details of proposed or actual pricing, information about target or key customers or expansion plans) in or around NEPIC meetings, including at unofficial get-togethers or over coffee/lunch.